Impact of dramatic weight loss with the new injectable medications on reproduction in healthy non–polycystic ovary syndrome obese women
The intake of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in obese women with polycystic ovary syndrome (PCOS) demonstrated improvement in metabolic and reproductive symptoms; however, their impact in non-PCOS state is unclear. This review critically analyzes data pertaining to GLP-1 RAs...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | F&S Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666334124001466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|